327 related articles for article (PubMed ID: 16840830)
41. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
[TBL] [Abstract][Full Text] [Related]
42. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
[TBL] [Abstract][Full Text] [Related]
43. Novel Germline p.Gly42Val
Koehler VF; Jungheim K; Groß U; Iacovazzo D; Mann A; Korbonits M
Ann Clin Lab Sci; 2017 Sep; 47(5):606-610. PubMed ID: 29066490
[TBL] [Abstract][Full Text] [Related]
44. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
45. Six novel MEN1 gene mutations in sporadic parathyroid tumors.
Cetani F; Pardi E; Giovannetti A; Cerrai P; Borsari S; Vignali E; Picone A; Cianferotti L; Miccoli P; Pinchera A; Marcocci C
Hum Mutat; 2000 Nov; 16(5):445. PubMed ID: 11058905
[TBL] [Abstract][Full Text] [Related]
46. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
47. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
[TBL] [Abstract][Full Text] [Related]
48. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
49. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
50. Increased menin expression in sporadic pituitary adenomas.
Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
[TBL] [Abstract][Full Text] [Related]
51. Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism.
Ohye H; Sato M; Matsubara S; Miyauchi A; Imachi H; Murao K; Takahara J
Endocr J; 1998 Dec; 45(6):719-23. PubMed ID: 10395226
[TBL] [Abstract][Full Text] [Related]
52. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
53. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.
Sato M; Matsubara S; Miyauchi A; Ohye H; Imachi H; Murao K; Takahara J
J Med Genet; 1998 Nov; 35(11):915-9. PubMed ID: 9832038
[TBL] [Abstract][Full Text] [Related]
54. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
55. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
56. An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese.
Abe T; Yoshimoto K; Taniyama M; Hanakawa K; Izumiyama H; Itakura M; Matsumoto K
J Clin Endocrinol Metab; 2000 Mar; 85(3):1327-30. PubMed ID: 10720085
[No Abstract] [Full Text] [Related]
57. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
58. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
59. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
60. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
Klein RD; Salih S; Bessoni J; Bale AE
Genet Med; 2005 Feb; 7(2):131-8. PubMed ID: 15714081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
